Efficacy and safety of Guselkumab for moderate-to-severe psoriasis: A systematic review and meta-analysis of randomized controlled trials
Dermatology Practical & Conceptual · 30.04.2026 · 16 (2) · 6534
DOI: 10.5826/dpc.1602a6534 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 30.04.2026. Verfasst von Laura Ghanem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Psoriasis, a chronic inflammatory skin condition, affects 125 million worldwide. Current treatments provide symptomatic relief but face limitations. Guselkumab shows promise for moderate-to-severe psoriasis.
Objective
We aimed to conduct a systematic review and meta-analysis exploring the safety and efficacy of guselkumab in moderate-to-severe psoriasis.
Methods
We searched PubMed, EMBASE, and Cochrane Library for randomized controlled trials (RCTs) comparing guselkumab to placebo in moderate-to-severe psoriasis. Primary endpoints: Investigators’ Global Assessment (IGA) 0, Psoriasis Area and Severity Index (PASI) 90, and ≥1 adverse event (AE). Secondary endpoints: IGA 0/1, PASI75, PASI100, Dermatology Life Quality Index (DLQI), and ≥1 severe AE. RStudio was used for statistical analyses.
Results
We included 1607 patients from 6 RCTs. Guselkumab significantly increased odds of IGA 0 (odds ratio (OR) OR: 73.87; 95%confidence interval (CI): 32.53-167.73; P
Autor:innen und Institutionen
- Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
- Faculty of Pharmacy, Zagazig University, Egypt.
- Dermatology Department, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain.
Zitieren
APA
Ghanem, L., Moubarak, A., Khater, J., Yakout, I. A., & Velasco-Tamariz, V. (2026). Efficacy and safety of Guselkumab for moderate-to-severe psoriasis: A systematic review and meta-analysis of randomized controlled trials. Dermatology Practical & Conceptual, 16(2), 6534. https://doi.org/10.5826/dpc.1602a6534
Vancouver
Ghanem L, Moubarak A, Khater J, Yakout IA, Velasco-Tamariz V. Efficacy and safety of Guselkumab for moderate-to-severe psoriasis: A systematic review and meta-analysis of randomized controlled trials. Dermatology Practical & Conceptual. 2026;16(2):6534. doi:10.5826/dpc.1602a6534
BibTeX
@article{Ghanem2026,
author = {Ghanem, Laura and Moubarak, Antonia and Khater, Jacinthe and Yakout, Ibrahim A and Velasco-Tamariz, Virginia},
title = {Efficacy and safety of Guselkumab for moderate-to-severe psoriasis: A systematic review and meta-analysis of randomized controlled trials},
journal = {Dermatology Practical & Conceptual},
year = {2026},
volume = {16},
number = {2},
pages = {6534},
doi = {10.5826/dpc.1602a6534}
}
EUVIMED